Pharmafile Logo
Pharmafocus logo
Advanced Search

CMA fines Advanz over £100 million over pricing of crucial thyroid drug

July 30, 2021
Medical Communications

The CMA has fined the pharmaceutical company Advanz over £100 million after it charged excessive and unfair prices for supplying …

News

FDA: Viatris’ insulin deemed ‘interchangeable’ biosimilar

July 30, 2021
Medical Communications

Viatris has become the first company to secure FDA approval for a biosimilar product that is considered completely interchangeable with …

News

COVID travel update: Double jabbed from US and EU could avoid UK quarantine

July 30, 2021
Medical Communications

UK ministers are close to deciding that double vaccinated people from the US and many EU countries will not have …

News

Positive data reported on Alnylam’s investigational RNAi therapeutic for ultra-rare disease

July 30, 2021
Medical Communications

Alnylam Pharmaceuticals has announced that its investigational RNAi therapeutic, lumasiran, has performed well in a Phase III study for the …

News

FDA grants Huntingdon disease treatment orphan-drug designation

July 30, 2021
Medical Communications

The FDA has granted VICO’s investigational therapy for Huntingdon disease, VO659, orphan-drug designation. This news comes just one month after …

News

Urine test developed that can detect brain tumours for first time

July 29, 2021

Scientists from Cancer Research UK have developed a simple urine test that can detect a common type of brain tumours …

News

Study shows significant improvement of survival in infants with SMA

July 29, 2021
sma

Results from the Evrysdi part 2 global FIREFISH study show significant improvement in survival and motor milestones in babies with …

News

$500,000 grant awarded to NRG Therapeutics for Parkinson’s research

July 29, 2021

The Michael J Fox Foundation for Parkinson’s Research (MJFF) has awarded a $500,000 grant to NRG Therapeutics to support its …

News
regeneron

Dupilumab meets primary endpoint in skin disease Phase III trial

July 29, 2021

Dupilumab has met its primary endpoint in a Phase III trial for patients with moderate-to-severe chronic spontaneous urticaria (CSU), an …

News
nhs_old_hospital_1

NHS England appoints first ever female Chief Executive

July 29, 2021

NHS England has announced the appointment of Amanda Prichard, the first woman to hold the position. She will replace Sir …

News
andrei_r_-_shutterstock_1935537274_720

Complix and Jiangsu Nhwa to collaborate on treatment of CNS Diseases

July 28, 2021
Research and Development

Complix has signed a global collaboration and license agreement with Jiangsu Nhwa Pharmaceutical Co, to develop Cell Penetrating Alphabodies (CPABs), …

News

US to ship nearly 10 million vaccine doses to Nigeria and South Africa

July 28, 2021
Research and Development

On Wednesday the US government will ship 4 million vaccine does to Nigeria and 5.66 million doses to South Africa. …

News

CanSino’s inhaled COVID vaccine performs well in early trials

July 28, 2021
Manufacturing and Production, Research and Development

Early-stage data, published in The Lancet on Monday, has shown CanSino Biologic’s inhaled COVID-19 vaccine was able to stimulate neutralising …

News

Biogen withdrew Aduhelm paper when asked for edits from JAMA

July 28, 2021
Research and Development

The makers of the controversial drug Aduhelm, Biogen, withdrew its paper that analysed the drug’s results that was submitted to …

News
astrazeneca_sign_sky

AstraZeneca & Regeneron to develop small molecule obesity treatment

July 28, 2021
Manufacturing and Production, Research and Development

AstraZeneca and Regeneron have announced a collaboration to research, develop and commercialise small molecule compounds directed against the GPR75 target …

News

Tokyo daily COVID cases hit record high

July 27, 2021
Manufacturing and Production, Medical Communications

On Tuesday Tokyo reported 2,848 daily coronavirus infections, the city’s highest rate since the pandemic began. The new infection record …

News
andrei_r_-_shutterstock_1935537274_720

Byondis and Glycotope to collaborate on antibodies against novel GlycoTargets

July 27, 2021
Manufacturing and Production

Byondis and Glycotope have entered into a platform access agreement to discover and develop antibodies that target specific tumour-associated protein/carbohydrate …

News

BioNTech set to develop first mRNA malaria vaccine

July 27, 2021
Manufacturing and Production, Research and Development

Buliding on the success of its COVID-19 vaccine, BioNTech has announced the development of the first mRNA vaccine against malaria, …

News

Antibodies from Sinovac’s COVID-19 vaccine fade after 6 months, study finds

July 27, 2021
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

A Chinese laboratory study has found that antibodies from Sinovac Biotech’s COVID-19 vaccine drop below a key threshold around six …

News

Purdue Pharma votes for bankruptcy plan to pay for its role in US opioid crisis

July 27, 2021
Manufacturing and Production

Oxycontin makers Purdue Pharma have voted in favour of its bankruptcy reorganisation plan that will provide billions of dollars to …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026